Biologically Different Subgroups of Invasive Ductal Carcinoma of the Pancreas
Open Access
- 1 June 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (11), 3772-3779
- https://doi.org/10.1158/1078-0432.ccr-03-0120
Abstract
Purpose: Among invasive ductal carcinomas of the pancreas (IDCP), there is a morphologically characteristic subgroup accompanied by abundant intraductal carcinoma components (ICCs). With the aim of determining whether ICC-rich IDCP are biologically different from ICC-poor IDCP, the expression status of Dpc4 protein was analyzed. Experimental Design: A total of 43 IDCP was subdivided into two groups: (a) ICC-rich IDCP (ICCs area occupies ≥10% of the entire tumorous area); and (b) ICC-poor IDCP (with Results: In a total of 43 IDCP, there were 23 ICC-rich IDCP and 20 ICC-poor IDCP. Dpc4-positive immunostaining was observed in the invasive carcinoma component of ICC-rich IDCP, ICC-poor IDCP, and ICs from IPMN in 18 of 23 (78%), 4 of 20 (20%), and 7 of 10 (70%) cases, respectively. In the intraductal component, positive staining for Dpc4 was found in 20 of 23 (87%), 3 of 7 (41%), and 8 of 10 (80%) cases, respectively. Dpc4 expression was found in both the invasive and ICC components of ICC-rich IDCP, similar to that found in IC derived from IPMN, whereas the expression of Dpc4 was largely diminished in ICC-poor IDCP. Conclusions: Morphologically distinct subgroups of invasive ductal carcinomas of the pancreas, namely ICC-rich IDCP and ICC-poor IDCP, are also biologically distinguishable as revealed by the differential expression of Dpc4.Keywords
This publication has 23 references indexed in Scilit:
- The Intraductal Carcinoma Component Is a Significant Prognostic Parameter in Patients with Invasive Ductal Carcinoma of the PancreasJapanese Journal of Cancer Research, 2002
- Direct Correlation between Proliferative Activity and Dysplasia in Pancreatic Intraepithelial Neoplasia (PanIN): Additional Evidence for a Recently Proposed Model of ProgressionLaboratory Investigation, 2002
- Intraductal papillary‐mucinous neoplasms of the pancreasCancer, 2001
- Allelic Loss Is Often the First Hit in the Biallelic Inactivation of the p53 and DPC4 Genes During Pancreatic CarcinogenesisThe American Journal of Pathology, 2001
- Pancreatic Intraepithelial NeoplasiaThe American Journal of Surgical Pathology, 2001
- Dpc-4 Protein Is Expressed in Virtually All Human Intraductal Papillary Mucinous Neoplasms of the PancreasThe American Journal of Pathology, 2000
- Molecular Analysis of Microdissected Tumors and Preneoplastic Intraductal Lesions in Pancreatic CarcinomaThe American Journal of Pathology, 2000
- Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic AdenocarcinomasThe American Journal of Pathology, 2000
- Intraductal papillary-mucinous tumors of the pancreas: Clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo ClinicGastroenterology, 1996
- DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1Science, 1996